K&L Gates

Amarchand Mangaldas and K&L Gates advised US-based Par Pharmaceuticals and its wholly-owned Indian subsidiary Par Formulations on its acquisition of Chennai-based Ethics Biolabs, which was advised by HSB Partners.

Amarchand Delhi partners Amit Kumar and Arvind Sharma, principal associate designate Janani Sekhar and senior associate Ananda Malhotra acted for Par Pharmaceuticals.

HSB partners TK Bhaskar and Varun Sriram with associate Anantha Krishnan Iyer acted for Ethics Biolabs and its selling promoters. Ethics conducts “bioavailability, bioequivalence, pharmacokinetic and clinical end point studies for pharmaceutical and biotechnology companies”, started an Amarchand press release. The value of the deal, which closed on 14 January, was confidential.

Majmudar & Co and K&L Gates have advised on e-commerce enterprise Rearden Commerce’s world-wide acquisition of Ketera Technologies, which was advised by DLA Piper and Thakker & Thakker that will cease operating at the end of this year.